Implementing genomic medicine in New Zealand

Genomic sequencing is a transformative technology, and its integration and implementation in the practice of medicine requires systemwide change. Genomic technology is already influencing many areas of medicine: rare disease, reproductive health, cancer, pharmacogenetics and infectious disease. Ensuring genomic tests are available and are adopted in an effective and efficient way requires forethought and simultaneous change across multiple areas of health. Beyond the technical requirements of sequencing and bioinformatics capacity, planning will need to address data integration and interpretation, workforce capacity and capability, public acceptability, government engagement and ethical and legislative issues. To ensure all these considerations are managed, many states or nations have developed policy frameworks or strategies. Implementation science enables us to understand the factors that support adoption of new technologies. The lessons learnt from other jurisdictions who have implemented genomic medicine programmes clearly support the need for a coordinated whole of systems approach. New Zealand should heed these lessons. New Zealand needs a genomic medicine strategy.

Authors

Institutions

Publication Details

Journal
Journal of the Royal Society of New Zealand
Published
2024-11-06
DOI
https://doi.org/10.1080/03036758.2024.2392804
Primary Topic
BRCA gene mutations in cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Implementing genomic medicine in New Zealand

Richard King
Journal of the Royal Society of New Zealand
BRCA gene mutations in cancer
article

Implementing genomic medicine in New Zealand

Richard King
article en

Abstract

Genomic sequencing is a transformative technology, and its integration and implementation in the practice of medicine requires systemwide change. Genomic technology is already influencing many areas of medicine: rare disease, reproductive health, cancer, pharmacogenetics and infectious disease. Ensuring genomic tests are available and are adopted in an effective and efficient way requires forethought and simultaneous change across multiple areas of health. Beyond the technical requirements of sequencing and bioinformatics capacity, planning will need to address data integration and interpretation, workforce capacity and capability, public acceptability, government engagement and ethical and legislative issues. To ensure all these considerations are managed, many states or nations have developed policy frameworks or strategies. Implementation science enables us to understand the factors that support adoption of new technologies. The lessons learnt from other jurisdictions who have implemented genomic medicine programmes clearly support the need for a coordinated whole of systems approach. New Zealand should heed these lessons. New Zealand needs a genomic medicine strategy.

Journal of the Royal Society of New ZealandVol. 55(6)
Canterbury Health Laboratories (NZ), University of Otago (NZ)
Openalex Percentile: Top 77%
BRCA gene mutations in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Implementing genomic medicine in New Zealand — Richard King · Journal of the Royal Society of New Zealand (2024) | TGRS Research Map | TGRS